arrow
E

Evangeline R. Jackson

University of Newcastle
H指数:10
被引数:454

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Leveraging the immunomodulatory effects of dordaviprone (ONC201) to induce long-term survival response in diffuse midline glioma patients and models

利用dordaviprone(ONC201)的免疫调节作用,在弥漫性中线胶质瘤患者和模型中诱导长期生存反应

2025-11-010
OAAI
ENHANCING GENOME ANALYSIS WITH WHOLE PROTEOME PROFILING FOR IMPROVED THERAPEUTIC DECISION MAKING IN DIFFUSE MIDLINE GLIOMA

通过全蛋白质组分析增强基因组分析,以改善弥漫性中线胶质瘤的治疗决策制定

2025-11-010
OAAI
Precision Targeting of PI3K/mTOR in Diffuse Midline Glioma: GCT007 as a Novel Brain-Penetrant PIK3CA Inhibitor

弥漫性中线胶质瘤中PI3K/mTOR的精确靶向:GCT007作为新型脑穿透性PIK3CA抑制剂

2025-11-010
OAAI
DRD2 ANTAGONISM RESCUES IMMUNE-TUMOR SURVEILLANCE, WARMING THE TUMOR IMMUNE MICROENVIRONMENT OF DIFFUSE MIDLINE GLIOMA MODELS
2024-06-180
OAAI
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma
2024-02-068
OAAI
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma

高突变弥漫性内在性脑桥胶质瘤中的治疗性HDAC抑制

2023-09-013
OAAI
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
2023-05-0530
OAAI
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies
2023-03-2811
PRE
Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma

德国来源的ONC201治疗H3K27M-mutant弥漫性内源性桥脑胶质瘤的临床前评估和临床评估

2021-11-1931
OAAI